Article

Analytical Validation of a Pan-Cancer NGS Assay for In-House Liquid Biopsy Testing: An International Multicenter Study

2024-10-19

Abstract excerpt

<h4>Background</h4> Liquid biopsy (LBx) assays are transforming precision oncology by the screening of genomic alterations in cfDNA. These assays provide a less invasive alternative to tissue biopsies, which are not always feasible. Molecular pathology laboratories require LBx assays that detect variants at low allele frequencies using standardized methods. <h4>Methods</h4> This study evaluated the Hedera Profilin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d881021a-19a7-5756-84b9-fb95ef471c51
DOI: 10.1101/2024.10.17.24313324

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Analytical Validation of a Pan-Cancer NGS Assay for In-House Liquid Biopsy Testing: An International Multicenter StudyDOI 10.1101/2024.10.17.24313324Read

Analytical Validation of a Pan-Cancer Next-Generation Sequencing Assay for In-House Liquid Biopsy Testing: An International Multicenter Study.Semantic proximity Read

Validation of a DNA-Based Next-Generation Sequencing Test for Molecular Diagnostic Variant and Fusion Detection in Formalin-Fixed, Paraffin-Embedded Tissue Specimens and Liquid Biopsy Plasma/Cell-Free DNA Samples.Semantic proximity Read

Development and Performance Validation of a Comprehensive Liquid Biopsy Genotyping Panel for Pan-cancer Analysis.Semantic proximity Read

Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNASemantic proximity Read

Technical validation of a fully integrated NGS platform in real-world practice of Italian referral institutionSemantic proximity Read

Implementation of an ISO 15189 accredited next generation sequencing service for cell-free total nucleic acid (cfTNA) analysis to facilitate driver mutation reporting in blood: the experience of a clinical diagnostic laboratorySemantic proximity Read

Clinical validation of Whole Genome Sequencing for cancer diagnosticsSemantic proximity Read

Analytic and clinical validation of a pan-cancer NGS liquid biopsy test for the detection of copy number amplifications, fusions and exon skipping variants.Semantic proximity Read

Current practices and guidelines for clinical next-generation sequencing oncology testing.Semantic proximity Read

Rapid genomic profiling of circulating tumor DNA in non-small cell lung cancer using Oncomine Precision Assay with GenexusTM integrated sequencerSemantic proximity Read

Enhanced specificity of high sensitivity somatic variant profiling in cell-free DNA via paired normal sequencing: design, validation, and clinical experience of the MSK-ACCESS liquid biopsy assaySemantic proximity Read

Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics.Semantic proximity Read